Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces that the Center for Devices and Radiological Health (CDRH) ...
In November 2024 we received FDA Breakthrough Device Designation for the SCD for use in chronic dialysis, our first such designation for a chronic indication. This is our fourth FDA award of ...
Plus, Donald Trump is set to visit the White House to meet with President Joe Biden for a symbolic meeting to signify a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback